Inviragen's Acquisition

Inviragen was acquired by Takeda Pharmaceutical on May 08, 2013.

Inviragen is focused on developing vaccines to protect against infectious diseases worldwide. Inviragen's vaccine to protect against dengue fever is in Phase 2 clinical testing. A vaccine designed to …

Articles about Inviragen's Acquisition: